Evidence map›Paper›PMID 26647386›Full record

ArticleDiabetes2016

Monitoring C-Peptide Storage and Secretion in Islet β-Cells In Vitro and In Vivo.

Shuaishuai Zhu, Dennis Larkin, Shusheng Lu, Candice Inouye, Leena Haataja, Arfah Anjum, Robert Kennedy, David Castle, Peter Arvan

Abstract read
In one paragraph

Article in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Distinct states of proinsulin misfolding in MIDY.Cellular and molecular life sciences : CMLS · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Functional analysis of islet cells in vitro, in situ, and in vivo.Seminars in cell & developmental biology · 2020
    Review
  16. Article
  17. Article
  18. The Role of Glycation on the Aggregation Properties of IAPP.Frontiers in molecular biosciences · 2020
    Article
  19. A Newly Discovered Phenylethanoid Glycoside fromMolecules (Basel, Switzerland) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shuaishuai ZhuDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, MI.
Dennis LarkinDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, MI.
Shusheng LuDepartment of Chemistry, University of Michigan, Ann Arbor, MI.
Candice InouyeDepartment of Cell Biology, University of Virginia, Charlottesville, VA.
Leena HaatajaDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, MI.
Arfah AnjumDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, MI.
Robert KennedyDepartment of Chemistry, University of Michigan, Ann Arbor, MI.ORCID http://orcid.org/0000-0001-9417-0534
David CastleDepartment of Cell Biology, University of Virginia, Charlottesville, VA.ORCID http://orcid.org/0000-0002-3075-1580
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical Center, Ann Arbor, MI parvan@umich.edu.
University of Michigan · USUniversity of Virginia · US

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
MICROELECTRODE AND MICRODIALYSIS-BASED INSULIN SENSORSR01DK046960 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 1993 to 2020
$3.3M
Design and Use of Methods for Peptide Secretion Studies - Diversity SupplementR37DK046960 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 2006 to 2015
$3.0M
ABCs of Cholesterol Regulation in the Insulin Secretory PathwayR01DK091296 · NIDDK · UNIVERSITY OF VIRGINIA · PI CASTLE, JOHN DAVID · 2012 to 2015
$1.4M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS P30-DK-089503NIDDK NIH HHS P60 DK020572NIDDK NIH HHS P60-DK-20572NIDDK NIH HHS R01 DK046960NIDDK NIH HHS R01 DK048280NIDDK NIH HHS R01 DK091296NIDDK NIH HHS R01-DK-091296NIDDK NIH HHS R01-DK-48280NIDDK NIH HHS R37 DK046960NIDDK NIH HHS R37-DK-046960
6 · The paper itself

Abstract

Human proinsulin with C-peptide-bearing Superfolder Green Fluorescent Protein (CpepSfGFP) has been expressed in transgenic mice, driven by the Ins1 promoter. The protein, expressed exclusively in β-cells, is processed and stored as CpepSfGFP and human insulin comprising only ∼0.04% of total islet proinsulin plus insulin, exerting no metabolic impact. The kinetics of the release of insulin and CpepSfGFP from isolated islets appear identical. Upon a single acute stimulatory challenge in vitro, fractional release of insulin does not detectably deplete islet fluorescence. In vivo, fluorescence imaging of the pancreatic surface allows, for the first time, visual assessment of pancreatic islet insulin content, and we demonstrate that CpepSfGFP visibly declines upon diabetes progression in live lepR(db/db) mice. In anesthetized mice, after intragastric or intravenous saline delivery, pancreatic CpepSfGFP (insulin) content remains undiminished. Remarkably, however, within 20 min after acute intragastric or intravenous glucose delivery (with blood glucose concentrations reaching >15 mmol/L), a small subset of islets shows rapid dispossession of a major fraction of their stored CpepSfGFP (insulin) content, whereas most islets exhibit no demonstrable loss of CpepSfGFP (insulin). These studies strongly suggest that there are "first responder" islets to an in vivo glycemic challenge, which cannot be replicated by islets in vitro.

Indexed as

AnimalsBlood GlucoseC-PeptideDiabetes MellitusDisease ProgressionGlucoseGreen Fluorescent ProteinsHumansInsulin-Secreting CellsIn Vitro TechniquesMiceMice, TransgenicMicroscopy, Electron, TransmissionProinsulinBlood GlucoseC-PeptideGlucoseGreen Fluorescent ProteinsProinsulin

Identifiers

PMID26647386
PMCPMC4764152
OpenAlexW2205277535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.